Summit Therapeutics Stock Performance
as on November 12, 2026 at 7:54 am IST
Day's Low
Day's High
$16.59$17.88
0.84%
Downside
6.87%
Upside
52 Week's Low
52 Week's High
$12.07$29.2327.85%
Downside
74.72%
Upside
Summit Therapeutics share price movements today
- Previous Close
- $17.83
- Open
- $17.87
- Volume
- 3.1M
- Market Cap
- $13.1B
- Day's Low - High
- $16.59 - $17.88
- 52 Week Low - High
- $12.07 - $29.23
Summit Therapeutics Historical Returns
- 1 Month Return
- + 1.36 %
- 3 Month Return
- + 17.96 %
- 1 Year Return
- -6.94 %
- 3 Year Return
- + 835.96 %
- 5 Year Return
- + 237.69 %
Summit Therapeutics Stock Fundamentals & Key Indicators
Check Summit Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$13.1B
EPS (TTM)
-1.07
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.66
Industry PE ratio
8.00
PEG Ratio
36.25
EBITDA
-832.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-138.81%
Summit Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Summit Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $13.1B | 237.69% | -16.66 | 0.00% | 0.00% | |
| Neutral | $101.5B | 11.08% | -35.48 | 28.00% | 0.00% | |
| StrongBuy | $46.5B | NA | 68.25 | 88.39% | 0.00% | |
| StrongBuy | $138.7B | 194.77% | 34.99 | 85.57% | 0.00% | |
| Buy | $93.5B | 46.19% | 19.51 | 85.77% | 0.41% |
Stock Returns calculator for Summit Therapeutics Stock including INR - Dollar returns
The Summit Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Summit Therapeutics investment value today
Current value as on today
₹92,463
Returns
Returns from Summit Therapeutics Stock
Dollar Impact
₹5,146 (+5.15%)
Analyst Recommendation on Summit Therapeutics Stock
Based on 9 analysts
55.56%
Buy
44.44%
Hold
0.00%
Sell
Based on 9 analysts, 55.55555555555556% of analysts recommend a 'BUY' rating for Summit Therapeutics. Average target price of $29.85
Summit Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Summit Therapeutics.
What analysts predicted
43.95%UPSIDE
Target Price
$29.85
Current Price
$16.73
Analyzed by
9 Analysts
High
$43
Target
$29.85
Low
$16
Summit Therapeutics target price $29.85, a slight upside of 43.95% compared to current price of $16.73. According to 9 analysts rating.
Indian Investors' Interest in Summit Therapeutics Stock
Investment in Summit Therapeutics Shares on INDmoney has dropped by -25.17% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Summit Therapeutics Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Summit Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Summit Therapeutics Annual Profit & Loss
All numbers in Millions USD
Summit Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Summit Therapeutics Annual Cash Flow
All numbers in Millions USD
Summit Therapeutics News & Key Events
Today's Timeline - 09 November
Mon, 03:53 PM
-Summit Therapeutics' Ivonescimab faces FDA scrutiny after Phase 3 trial failed to show significant survival benefit.
Tue, 05:51 AM
-Summit Therapeutics stock priced at US$17.84 raises valuation concerns despite AstraZeneca's US$2b investment.
Insights on Summit Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, SMMT has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, SMMT stock has moved up by 10.3%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 849.8% return, outperforming this stock by 856.7%
About Summit Therapeutics
| Organisation | Summit Therapeutics |
| Headquarters | 601 Brickell Key Drive, Miami, FL, 33131, US |
| Industry | Biotechnology |
| CEO | Robert W. Duggan |
Key Management of Summit Therapeutics
Name | Title |
|---|---|
Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-CEO, President & Director |
Prof. Kay Elizabeth Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
Mr. Nathan LiaBraaten | Senior Director of Investor Relations |
Dr. Elaine Carla Stracker J.D., Ph.D. | Chief Legal Officer |
Dr. Wang Clow Fong ScD | Chief Biometrics Officer |
Mr. Robert W. Duggan | Co-CEO & Executive Chairman |
Mr. Manmeet Singh Soni CPA | COO, CFO & Director |
Mr. Bhaskar Anand | Chief Accounting Officer & Head of Finance |
Mr. Dave Gancarz CPA | Chief Business & Strategy Officer |
Dr. Urte Gayko Ph.D. | Chief Regulatory, Quality & Pharmacovigilance Officer |
FAQs
What is Summit Therapeutics share price today?
Summit Therapeutics share price today is $16.73 as on . Summit Therapeutics share today touched a day high of $17.88 and a low of $16.59.
What is the 52 week high and 52 week low for Summit Therapeutics share?
Summit Therapeutics share touched a 52 week high of $29.23 on and a 52 week low of $12.07 on . Summit Therapeutics stock price today i.e. is trending at $16.73,which is 42.76% down from its 52 week high and 38.61% up from its 52 week low.
What is Summit Therapeutics's market capitalisation today?
Summit Therapeutics market capitalisation is $0.01T as on .
How to invest in Summit Therapeutics Stock (SMMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Summit Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Summit Therapeutics Stock (SMMT) from India?
Indian investors can start investing in Summit Therapeutics (SMMT) shares with as little as ₹93.68000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Summit Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Summit Therapeutics share’s latest price of $16.73 as on November 12, 2026 at 2:24 am IST, you will get 0.5977 shares of Summit Therapeutics. Learn more about
fractional shares .
What are the returns that Summit Therapeutics has given to Indian investors in the last 5 years?
Summit Therapeutics stock has given 237.69% share price returns and 26.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?